KWM
AMGN icon

Kingsview Wealth Management’s Amgen AMGN Stock Holding History

Kingsview Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$3K – 446
2019
Q2 		$3K Buy
200
+100
+100% +$17.9K ﹤0.01% 427
2019
Q1 		$1K Buy
+100
New +$19.1K ﹤0.01% 469
2017
Q3 		– Sell
-1,000
Closed -$1K – 366
2017
Q2 		$1K Buy
+1,000
New +$163K ﹤0.01% 324

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Kingsview Wealth Management's AMGN Position: Q1 2026 in Review

Kingsview Wealth Management reduced its Amgen (AMGN) stake by 3.8% in Q1 2026, selling an estimated $516K and leaving 36,365 shares worth $12.8M. The position accounts for 0.17% of the portfolio, ranked #110.

Kingsview Wealth Management first reported a position in AMGN in Q1 2017 and has held it in 37 quarters since. The position peaked at $18M in Q1 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kingsview Wealth Management held 36,365 shares of Amgen worth $12.8M as of Q1 2026.
  • Kingsview Wealth Management sold 1,447 Amgen shares in Q1 2026, an estimated $516K.
  • Amgen made up 0.17% of Kingsview Wealth Management's portfolio in Q1 2026, its #110 holding.
  • Kingsview Wealth Management first reported a position in Amgen in Q1 2017 and has held it in 37 quarters since.
  • Kingsview Wealth Management's Amgen position peaked at $18M in Q1 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.